The Gilead Swiss Medical Fellowship Program awards grants to support innovative projects in five key areas: HIV, hepatology, oncology, cell therapy, and invasive fungal infections. These projects aim to advance medical science, develop reproducible models, and improve patient management and patient-centered care.
The evidence generated will help shape public health policy and clinical practices. It will also foster new collaborations within Switzerland. Projects incorporating patient feedback are prioritized. Interventional trials and practices are not in scope of the program. Proposals which include the usage or uptake of Gilead products cannot be supported within the Swiss Fellowship Program.
Funding may be awarded to projects focused on:
HIV
Hepatology
Oncology
Innovative, patient focused research in advanced breast cancer aiming to:
Cell Therapy
Invasive Fungal Infections
Research projects on epidemiology, risk factors and disease course of invasive fungal infections
„The Gilead Swiss Fellowship program is a pivotal funding program that allows to
improve the care of patients by supporting projects addressing real-life clinical gaps
or by supporting innovative projects to advance science. Importantly, this program
offers the opportunity to young researchers to increase their scientific independence
and enhance their research profile.“
- Prof. Dr. Catia Marzolini -
How to apply
Key dates and deadlines
Funding details
Funding restrictions
Assessment process
Applications can be submitted as of January
20th to March 31st 2025.
For questions or to submit your application,
please contact: [email protected]